RO7567132
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7567132, covering 2026-03-03 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors [Phase 1]